» Articles » PMID: 38304837

Analgesic, Anti-inflammatory and Molecular Docking Studies of -naproxen Derivatives

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Feb 2
PMID 38304837
Authors
Affiliations
Soon will be listed here.
Abstract

In the current studies two naproxen derivatives (NPD) were evaluated for analgesic and anti-inflammatory properties. The acetic acid and hot plate animal models were used to screen the compounds for analgesic potential. While the anti-inflammatory potential was evaluated through animal paw edema, induced by several inflammatory mediators (carrageenan, bradykinin, and prostaglandin E2), the xylene-induced ear edema was also used as an inflammatory model. Both NPDs showed significant (p < 0.001) antinociceptive effects in the acetic acid-induced writhing paradigm. In the case of the hot plate, the NPD  at the tested dose of 5 mg/kg enhanced the latency time after 60 min of injection, which remained significant (p < 0.001) up to the end of the experiment duration. The maximum percent inhibition of NPD was 87.53. The naloxone injection significantly lowered the latency time of NPD as compared to NPD . Regarding the anti-inflammatory effect, both of the tested NPDs demonstrated a significant reduction in paw edema against various inflammatory mediators, as mentioned above; however, the anti-inflammatory effect of NPD was better. The maximal percent inhibition by NPD and was 43.24 (after 60 min) and 45.93 (after 90 min). A considerable effect also resulted from xylene-induced ere edema. Further, a molecular docking study was carried out to investigate the binding modes of the NPD. The docking analysis revealed that the NPD significantly interacted with the COX2 enzyme. Furthermore, molecular dynamics simulation was carried out for the docked complexes. The MD simulation analysis revealed the high stability of the two naproxen derivatives.

Citing Articles

In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches.

Ajmal A, Danial M, Zulfat M, Numan M, Zakir S, Hayat C Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794122 PMC: 11124053. DOI: 10.3390/ph17050551.

References
1.
Voilley N . Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs). Curr Drug Targets Inflamm Allergy. 2004; 3(1):71-9. DOI: 10.2174/1568010043483980. View

2.
Wadood A, Ajmal A, Junaid M, Rehman A, Uddin R, Azam S . Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target. Curr Pharm Des. 2022; 28(36):3023-3032. DOI: 10.2174/1381612828666220728120523. View

3.
Rauf A, Uddin G, Siddiqui B, Khan A, Khan H, Arfan M . In-vivo antinociceptive, anti-inflammatory and antipyretic activity of pistagremic acid isolated from Pistacia integerrima. Phytomedicine. 2014; 21(12):1509-15. DOI: 10.1016/j.phymed.2014.07.015. View

4.
Rao P, Kabir S, Mohamed T . Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development. Pharmaceuticals (Basel). 2016; 3(5):1530-1549. PMC: 4033995. DOI: 10.3390/ph3051530. View

5.
Alotaibi B, Ajmal A, Hakami M, Mahmood A, Wadood A, Hu J . New drug target identification in by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulations. Heliyon. 2023; 9(7):e17650. PMC: 10336522. DOI: 10.1016/j.heliyon.2023.e17650. View